MRK, is presenting new long term data on its GARDASIL 9 and GARDASIL HPV vaccines at a major international HPV congress. The ...

In the latest close session, Merck (MRK) was up +1.31% at $115.68. The stock's change was more than the S&P 500's daily gain of 1.15%. At the same time, the Dow added 1.38%, and the tech-heavy Nasdaq ...

Investing.com-- Merck & Company (NYSE:MRK) is nearing a roughly $6 billion deal to acquire Terns Pharmaceuticals (NASDAQ:TERN ...

Is MRK a good stock to buy now? We came across a bullish thesis on Merck & Co., Inc. on Investomine’s Substack. In this ...

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Value Fund” ...

Today's Research Daily features new research reports on 16 major stocks, including Merck Co., Inc. (MRK), TotalEnergies SE ...

Merck (NYSE: MRK) has taken its shareholders on a wild ride of late -- from last March's record high of more than $130 to this May's low near $76 back to its current price of just a little more than ...

Shares of Merck & Co. Inc. MRK slipped 1.18% to $114.50 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.36% to 6,624.70 ...

Turning $10,000 into $50,000 in about five years would require a compound annual growth rate (CAGR) of almost 38%. That's an extremely tough task for any corporation, but can Merck (NYSE: MRK), a ...

Merck has increased its dividend for 14 consecutive years. Its 10-year dividend growth rate of 5.4% is only decent. Merck increased its revenue from $39.5 billion in FY 2015 to $64.2 billion in FY ...